NAVEEN PEMMARAJU to Drug Therapy, Combination
This is a "connection" page, showing publications NAVEEN PEMMARAJU has written about Drug Therapy, Combination.
Connection Strength
0.123
-
A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms. Am J Hematol. 2018 02; 93(2):277-285.
Score: 0.103
-
Phase II study of pomalidomide in combination with prednisone in patients with myelofibrosis and significant anemia. Leuk Res. 2014 Sep; 38(9):1126-9.
Score: 0.020